A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(20 sites)

Australia

Concord Repatriation General Hospital, Concord, New South Wales

Genesiscare North Shore, St Leonards, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Monash Health, Clayton, Victoria

Cabrini Hospital Malvern, Malvern East, Victoria

The Alfred Hospital, Melbourne, Victoria

Brazil

Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre

Instituto Dor de Pesquisa E Ensino Sao Paulo, São Paulo

Canada

Ciusss Nim Hscm, Montreal, Quebec

Jewish General Hospital, Montreal, Quebec

Ciusss de Lestrie Chus, Sherbrooke, Quebec

Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Québec

New Zealand

North Shore Hospital, Auckland

Auckland City Hospital, Auckland

Wellington Regional Hospital (Ccdhb), Wellington

South Korea

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi

Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Asan Medical Center, SongpaGu, Seoul Teugbyeolsi